The US Food and Drug Administration (FDA) is adding the risk of anaphylaxis to a new boxed warning of glatiramer acetate, a medicine for multiple sclerosis (MS). The agency issued the warning about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback